Literature DB >> 17043807

The effect of ultraviolet radiation on choroidal melanocytes and melanoma cell lines: cell survival and matrix metalloproteinase production.

Kenneth Lai1, Nick Di Girolamo, Robert M Conway, Martine J Jager, Michele C Madigan.   

Abstract

BACKGROUND: Ultraviolet radiation (UVR) can induce DNA damage and regulate the expression of factors important for tumour growth and metastasis, including matrix metalloproteinases (MMPs). Epidemiological studies suggest that chronic UVR exposure, especially during early adulthood, may be a risk factor in patients with choroidal melanoma. However, the effects of UV(R)-B on human choroidal melanocyte survival and growth are unknown. In this study, we investigated if UV(R)-B affected the in vitro survival, growth and MMP production of choroidal melanocytes and melanoma cells.
METHODS: Cultures of primary choroidal melanocytes and melanoma cell lines (OCM-1 and OCM-8) were exposed to UV(R)-B (0-30 mJ/cm(2)). The cell morphology and growth were examined, and cell viability was assessed using an MTT assay. Gelatin zymography was used to assess the enzymatic activity for MMP-2 and -9 in conditioned media following UV(R)-B treatment.
RESULTS: UV(R)-B > or =20 mJ/cm(2) was cytotoxic for choroidal melanocytes. Cytotoxic doses of 5 to 10 mJ/cm(2) were found for OCM-8 and OCM-1 melanoma cell lines. Low levels of UV(R)-B (2.5 and 3.5 mJ/cm(2)) significantly reduced melanoma cell viability after 48 h, although melanocyte viability was not affected by doses of UV(R)-B <10 mJ/cm(2). Conditioned media from melanoma cells and melanocytes displayed pro-MMP-2 activity independent of UV(R)-B. Control and UV(R)-B-treated OCM-1 cells secreted active MMP-2 up to 72 h. Pro-MMP-9 activity was seen from 36 h for control and UV(R)-B-treated OCM-1 and OCM-8 cells.
CONCLUSIONS: Melanocytes appeared more resistant to physiological doses of UV(R)-B than melanoma cells; the potential of melanocytes to initially survive DNA damage following UV(R)-B exposure may be relevant to the subsequent transformation of melanocytes to melanomas. Although UV(R)-B did not induce the production and/or activation of MMP-2 and -9 in melanocytes or melanoma cells, we are currently investigating whether DNA damage-response genes such as p53 and p21 can be regulated following UVR exposure, and whether they are important for choroidal melanoma development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043807     DOI: 10.1007/s00417-006-0444-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  55 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  Wavelength-specific effects on UVB-induced apoptosis in melanocytes. A study of Bcl-2/Bax expression and keratinocyte rescue effects.

Authors:  Cecilia A Bivik; Eva B Andersson; Inger K Rosdahl
Journal:  Melanoma Res       Date:  2005-02       Impact factor: 3.599

3.  Relative induction of cyclobutane dimers and cytosine photohydrates in DNA irradiated in vitro and in vivo with ultraviolet-C and ultraviolet-B light.

Authors:  D L Mitchell; J Jen; J E Cleaver
Journal:  Photochem Photobiol       Date:  1991-11       Impact factor: 3.421

4.  Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?

Authors:  A Väisänen; M Kallioinen; K von Dickhoff; L Laatikainen; M Höyhtyä; T Turpeenniemi-Hujanen
Journal:  J Pathol       Date:  1999-05       Impact factor: 7.996

5.  Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.

Authors:  R E Seftor; E A Seftor; N Koshikawa; P S Meltzer; L M Gardner; M Bilban; W G Stetler-Stevenson; V Quaranta; M J Hendrix
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: implications for cortical cataract formation.

Authors:  Nitin H Sachdev; Nick Di Girolamo; Timothy M Nolan; Peter J McCluskey; Denis Wakefield; Minas T Coroneo
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-11       Impact factor: 4.799

7.  Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.

Authors:  Sergiu T Leu; Suchitra Batni; Monte J Radeke; Lincoln V Johnson; Don H Anderson; Dennis O Clegg
Journal:  Exp Eye Res       Date:  2002-01       Impact factor: 3.467

8.  UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway.

Authors:  Nick Di Girolamo; Minas T Coroneo; Denis Wakefield
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

Review 9.  Ocular melanoma: a review and the relationship to cutaneous melanoma.

Authors:  Eva A Hurst; J William Harbour; Lynn A Cornelius
Journal:  Arch Dermatol       Date:  2003-08

10.  Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes.

Authors:  D N Hu; S A McCormick; R Ritch; K Pelton-Henrion
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-06       Impact factor: 4.799

View more
  3 in total

1.  Expression and distribution of MUC18 in human uveal melanoma.

Authors:  Kenneth Lai; Vidushi Sharma; Martine J Jager; R Max Conway; Michele C Madigan
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

2.  In-depth proteomic profiling of the uveal melanoma secretome.

Authors:  Martina Angi; Helen Kalirai; Samuel Prendergast; Deborah Simpson; Dean E Hammond; Michele C Madigan; Robert J Beynon; Sarah E Coupland
Journal:  Oncotarget       Date:  2016-08-02

3.  Shedding light on melanins within in situ human eye melanocytes using 2-photon microscopy profiling techniques.

Authors:  Ephrem Sitiwin; Michele C Madigan; Enrico Gratton; Svetlana Cherepanoff; Robert Max Conway; Renee Whan; Alexander Macmillan
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.